SCHEMBL16397347

SCHEMBL16397347

O=C(O)C1Oc2ccccc2C(=O)C1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.43
RET P07949 1/20 0.42
KDR P35968 1/20 0.42
ADORA3 P0DMS8 3/20 0.40
MAOB P27338 2/20 0.40
CYP19A1 P11511 2/20 0.40
KDM4E B2RXH2 2/20 0.40
AR P10275 2/20 0.40
HSD17B10 Q99714 1/20 0.40
POLB P06746 1/20 0.40
CASP6 P55212 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
ALOX15 P16050 2/20 0.39
CYP3A4 P08684 2/20 0.39
MAPT P10636 3/20 0.37
HTT P42858 2/20 0.37
HBB P68871 1/20 0.37
ALDH1A1 P00352 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1892218 0.81 RET (0.51) STK17BRETKDRADORA3MAOB
SCHEMBL9837501 0.81 RET (0.41) STK17BRETKDRADORA3MAOB
SCHEMBL7840884 0.78 RET (0.38) STK17BRETKDRADORA3MAOB
SCHEMBL29155508 0.77 POLB (0.43) MAOBPOLBCASP6LMNA
SCHEMBL1431562 0.77 RET (0.49) STK17BRETKDRADORA3MAOB
SCHEMBL28472788 0.75 RET (0.40) STK17BRETKDRADORA3MAOB
SCHEMBL10974720 0.75 POLB (0.47) KDM4EPOLBCASP6SMN1; SMN2HTT
SCHEMBL10974722 0.75 POLB (0.47) KDM4EPOLBCASP6SMN1; SMN2HTT
SCHEMBL4224331 0.72 MAPT (0.52) RETKDRMAOBCYP19A1KDM4E
SCHEMBL10852658 0.70 CYP19A1 (0.40) STK17BRETKDRADORA3MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3004073-A1 3-CARBOXY SUBSTITUTED COUMARIN DERIVATIVES WITH A POTENTIAL UTILITY FOR THE TREATMENT OF CANCER DISEASES Université catholique de Louvain (BE) 2016-04-13 EP disclosed
WO-2014195507-A1 3-CARBOXY SUBSTITUTED COUMARIN DERIVATIVES WITH A POTENTIAL UTILITY FOR THE TREATMENT OF CANCER DISEASES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2014-12-11 WO disclosed